Zealand Pharma A/S
Zealand Pharma A/S (ZLDPF) Stock Overview
Explore Zealand Pharma A/S’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
3.3B
P/E Ratio
3.28
EPS (TTM)
$12.55
ROE
0.48%
ZLDPF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Zealand Pharma A/S (ZLDPF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 50.89, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $107.46.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 3.28 and a market capitalization of 3.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.